TENS of thousands of people in England suffering from debilitating eczema could soon be free of agonising symptoms after a ...
How one woman went from a severe alopecia areata diagnosis to finding the right prescription treatment for her—and getting ...
When we’re born, we rely completely on the adults around us to keep us safe. They’re the ones expected to notice when ...
Incyte today announced the expansion of its Moments of Clarity program, which amplifies the voices of people living with chronic immune-mediated skin conditions. This year, the initiative introduces ...
New research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that the timing of when eczema begins, as well as how long it lasts and how ...
Chronic hand eczema is now considered a “common” skin disease in the United States, according to results from the CHECK study ...
More than 62,000 people in England with debilitating hand eczema could benefit from a new treatment that has been given the ...
Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
According to Nice, the rollout of delgocitinib could reduce outpatient procedures such as phototherapy, as well as freeing up ...
Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions First and only therapy to specifically target the ...
This story has been updated with new information. Texas Tech football defensive tackle Skyler Gill-Howard, a starter in every game this season, was carted off the field with his left leg immobilized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback